
UP-TO-DATE, RESEARCH BASED INFORMATION ABOUT PSYCHEDELICS.
Cost-effectiveness of psilocybin-assisted therapy for severe depression: exploratory findings from a decision analytic model
Psilocybin has the potential to be a cost-effective therapy for severe depression. This depends on the level of psychological support that is given to patients receiving psilocybin and the price of the drug itself. Further data on long-term outcomes are required to improve the evidence base.
Is the high cost of psychedelic therapy worth it?
In this column I will examine the costs and benefits of psychedelic-assisted therapy,
The economics of psychedelic-assisted therapies: A research agenda
We describe six types of economic analyses and their rationale for decisions and planning including the needs of health care payers.